AS/Spondyloarthritis
4 years ago
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by BMS, @HorizonNews , @SanofiGenzyme, @Novartis. All content chosen by RheumNow & its Faculty.
4 years ago
Dr. C. Bakewell reminds us that entheses can show inflammation and chronic changes. Pearl: Be sure to look at MSUS of the digits for enthesitis. #ACR20 #ACRbest @RheumNow https://t.co/D3nLGGv4ko
4 years ago
Vaccinate your pts against pneumococcal- it works! 595 vaccinated pts with RA & SpA vs 2379 nonvaccinated followed to 10 yrs showed 50% less pneumonia if vaccinated even though those pts had more infections prior. Limitation not RCT & not vaccine I use @RheumNow @CRASCRRheum https://t.co/SySEL19Gcn
Spondyloarthritis at ACR 2020: Dr. Lianne Gensler
San Francisco-based rheumatologist Dr. Lianne Gensler examines a wide range of spondyloarthritis topics at ACR 2020, including how to join up with others interested in spondyloarthritis; enthesitis; the utility of MRI for the diagnosis for axSpA; novel treatments; and the impact of drugs on disease modification.
4 years ago
New drug mechanisms for SpA. Nice to have expanding options
#ACR20 https://t.co/vlTwaiuuS3
4 years ago
Tofacitinib for the Treatment of Adult Patients with Ankylosing Spondylitis: Primary Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study https://t.co/F86K1Lqou7 #tofacitinib #AS Tofa works in AS , zoster no VTE seen NNH 20(per SAE) NNT 2.5(per ASAS40)
Inadequate Response in Spondylitis: Dr. Olga Petryna
Dr. Petryna discusses two abstracts being presented at the ACR 2020 meeting: #0359 and #0371.
There are some really interesting poster and abstract presentations on spondyloarthritis at the ACR Convergence 2020. I’ll be covering these topics, and discussing select individual posters and…
Non-radiographic axSpa ACR Abstracts: Dr. Rachel Tate
Dr. Rachel Tate discusses abstracts #0876 and #0448 presented at the ACR20 annual meeting.
Poster Hall